The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 30, 2018
Filed:
Feb. 17, 2016
Applicant:
Wake Forest University Health Sciences, Winston-Salem, NC (US);
Inventors:
Waldemar Debinski, Winston-Salem, NC (US);
Hetal Pandya, Wintson-Salem, NC (US);
Denise Mazess Herpai, Winston-Salem, NC (US);
Assignee:
Wake Forest University Health Sciences, Winston-Salem, NC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/20 (2006.01); A61K 47/48 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); A61K 38/08 (2006.01); A61K 38/10 (2006.01); C07K 14/54 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/2086 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 47/48246 (2013.01); A61K 47/48261 (2013.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/5437 (2013.01); A61K 38/00 (2013.01); C07K 2319/01 (2013.01); C07K 2319/55 (2013.01);
Abstract
A targeting peptide that specifically binds to an IL13 receptor (e.g., wherein said targeting peptide is not an IL13 fragment) is described. The targeting peptide is optionally conjugated to at least one effector molecule. In some embodiments, the peptide specifically binds to the IL13Rα2 protein.